A. Dupont

Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy.

M. Koutsilieris, J. Goméz, F. Labrie, 1993, The Journal of urology.

LOSS OF LUTEINIZING HORMONE BIOACTIVITY IN PATIENTS WITH PROSTATIC CANCER TREATED WITH AN LHRH AGONIST AND A PURE ANTIANDROGEN

F. Labrie, R. St-Arnaud, S. Kelly, 1986, Clinical endocrinology.

Serum prostate specific antigen as pre-screening test for prostate cancer.

J. Goméz, F. Labrie, L. Cusan, 1992, The Journal of urology.

Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration

F. Labrie, A. Dupont, L. Rousseau, 1988, Archives of sexual behavior.